Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction

The aim of this study was to evaluate the effects of Sacubitril/Valsartan (S/V) on clinical, laboratory and echocardiographic parameters and outcomes in a real-world population with heart failure with reduced ejection fraction (HFrEF). This was a prospective observational study enrolling patients wi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Sci Rep
Main Authors: Polito, Maria Vincenza, Silverio, Angelo, Rispoli, Antonella, Vitulano, Gennaro, Auria, Federica D’, De Angelis, Elena, Loria, Francesco, Gigantino, Alberto, Bonadies, Domenico, Citro, Rodolfo, Carrizzo, Albino, Galasso, Gennaro, Iaccarino, Guido, Vecchione, Carmine, Ciccarelli, Michele
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170843/
https://ncbi.nlm.nih.gov/pubmed/32313194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63801-2
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים